Insiders Femasys Inc.

Equities

FEMY

US31447E1055

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-24 EDT			5-day change	1st Jan Change
1.28 ^USD	+3.23%		+0.79%	+31.28%

05-09	Femasys Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-09	Earnings Flash (FEMY) FEMASYS Reports Q1 Revenue $271,140	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Femasys Inc. Appoints Richard Spector as Chief Commercial Officer	02-06	CI
Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer	11-30	CI
Femasys Inc. Appoints Joshua Silverman as Director	11-21	CI
Femasys Inc. Designates Daniel Currie as its Chief Operating Officer	23-08-10	CI
Femasys Inc. Announces Management Changes	23-06-15	CI
Femasys Inc. Appoints Christine Thomas as Senior Vice President of Regulatory and Clinical Affairs, Effective October 10, 2022	22-10-12	CI
Femasys Inc. Announces Board Changes	22-07-06	CI
Femasys Names Dov Elefant as CFO	22-02-24	MT
Femasys Inc. Appoints Dov Elefant to Chief Financial Officer, Effective February 28, 2022	22-02-24	CI
Femasys Inc. Announces the Appointment of Wendy Perrow, Transformational Biotech Entrepreneur, as New Board Member	22-01-20	CI
Femasys Inc. Announces the Appointment of Edward Evantash as Chief Medical Officer	21-09-01	CI
Femasys Appoints Fred Aslan and Charles Larsen to its Board of Directors	16-03-23	CI
Femasys Inc. Appoints Todd Creech as Chief Financial Officer	15-12-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer